229 related articles for article (PubMed ID: 27168718)
1. Coexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy.
Abu El-Asrar AM; Siddiquei MM; Nawaz MI; De Hertogh G; Mohammad G; Alam K; Mousa A; Opdenakker G
Mol Vis; 2016; 22():424-35. PubMed ID: 27168718
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.
Abu El-Asrar AM; Mohammad G; Allegaert E; Ahmad A; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
Mol Vis; 2018; 24():394-406. PubMed ID: 29853773
[TBL] [Abstract][Full Text] [Related]
3. Differential expression and localization of human tissue inhibitors of metalloproteinases in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
Acta Ophthalmol; 2018 Feb; 96(1):e27-e37. PubMed ID: 28391660
[TBL] [Abstract][Full Text] [Related]
4. Upregulated Expression of Heparanase in the Vitreous of Patients With Proliferative Diabetic Retinopathy Originates From Activated Endothelial Cells and Leukocytes.
Abu El-Asrar AM; Alam K; Nawaz MI; Mohammad G; Van den Eynde K; Siddiquei MM; Mousa A; De Hertogh G; Geboes K; Opdenakker G
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8239-47. PubMed ID: 26720478
[TBL] [Abstract][Full Text] [Related]
5. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Thrombin/Matrix Metalloproteinase-1/Protease-Activated Receptor-1 Chain in Proliferative Diabetic Retinopathy.
Abu El-Asrar AM; Alam K; Nawaz MI; Mohammad G; Van den Eynde K; Siddiquei MM; Mousa A; De Hertogh G; Opdenakker G
Curr Eye Res; 2016 Dec; 41(12):1590-1600. PubMed ID: 27261371
[TBL] [Abstract][Full Text] [Related]
7. Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.
Abu El-Asrar AM; Nawaz MI; Ola MS; De Hertogh G; Opdenakker G; Geboes K
Acta Ophthalmol; 2013 May; 91(3):e169-77. PubMed ID: 23387388
[TBL] [Abstract][Full Text] [Related]
8. The tumor necrosis factor superfamily members TWEAK, TNFSF15 and fibroblast growth factor-inducible protein 14 are upregulated in proliferative diabetic retinopathy.
Abu El-Asrar AM; De Hertogh G; Nawaz MI; Siddiquei MM; Van den Eynde K; Mohammad G; Opdenakker G; Geboes K
Ophthalmic Res; 2015; 53(3):122-30. PubMed ID: 25676319
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Alam K; Siddiquei MM; Mohammad G; Hertogh G; Mousa A; Opdenakker G
Acta Ophthalmol; 2017 Nov; 95(7):697-704. PubMed ID: 27860331
[TBL] [Abstract][Full Text] [Related]
10. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
Acta Ophthalmol; 2018 Jun; 96(4):e460-e467. PubMed ID: 29098793
[TBL] [Abstract][Full Text] [Related]
11. Galectin-1 studies in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Allegaert E; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
Acta Ophthalmol; 2020 Feb; 98(1):e1-e12. PubMed ID: 31318490
[TBL] [Abstract][Full Text] [Related]
12. Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy.
Abu El-Asrar AM; Struyf S; Mohammad G; Gouwy M; Rytinx P; Siddiquei MM; Hernández C; Alam K; Mousa A; De Hertogh G; Opdenakker G; Simó R
Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3189-3201. PubMed ID: 28654984
[TBL] [Abstract][Full Text] [Related]
13. Unbalanced Vitreous Levels of Osteoprotegerin, RANKL, RANK, and TRAIL in Proliferative Diabetic Retinopathy.
Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
Ocul Immunol Inflamm; 2018; 26(8):1248-1260. PubMed ID: 28914577
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
15. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
16. S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis.
Abu El-Asrar AM; Nawaz MI; De Hertogh G; Alam K; Siddiquei MM; Van den Eynde K; Mousa A; Mohammad G; Geboes K; Opdenakker G
Mol Vis; 2014; 20():1209-24. PubMed ID: 25253987
[TBL] [Abstract][Full Text] [Related]
17. Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy.
Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM; Van den Eynde K; Mousa A; De Hertogh G; Opdenakker G
PLoS One; 2013; 8(12):e85857. PubMed ID: 24392031
[TBL] [Abstract][Full Text] [Related]
18. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V
J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109
[TBL] [Abstract][Full Text] [Related]
19. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
